163 results
DEFC14A
DMKPQ
DMK Pharmaceuticals Corp
12 Oct 23
Proxy in contested solicitation
4:22pm
and willingness and ability to contribute positively to our decision-making process; (iii) commitment to understanding our business and our industry; (iv … will be not establish an employment or other service relationship between the Company and the Participant.
(e) Change in Time Commitment. In the event
PREC14A
DMKPQ
DMK Pharmaceuticals Corp
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
to our decision-making process; (iii) commitment to understanding our business and our industry; (iv) adequate time to attend and participate … .
(e) Change in Time Commitment. In the event a Participant’s regular level of time commitment in the performance of his or her services for the Company
8-K
EX-99.1
DMKPQ
DMK Pharmaceuticals Corp
8 Sep 23
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
4:50pm
the company signifies our new strategic vision and reinforces our commitment to a renewed corporate strategy. Along with our flagship approved treatment
8-K
EX-10.1
06747he41tb1dg8
24 Jul 23
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-10.3
hp1p72
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
DEFM14A
yzo90 pbmz
13 Apr 23
Proxy related to merger
4:52pm
DEFA14A
pbb 9s48nx
18 Aug 22
Additional proxy soliciting materials
3:07pm
DEFA14A
gwxa5ygi0u6j
29 Jul 22
Additional proxy soliciting materials
3:35pm
8-K
EX-99.1
fbfvh9bo2ovpbjv2z1y
29 Jul 22
Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals’ Stockholders Vote FOR Critical Proposals at Upcoming Annual Meeting
3:32pm
DEFA14A
6as 7nzozl3e
21 Jul 22
Additional proxy soliciting materials
4:23pm